Hochschulschrift
Acute panmyelosis with myelofibrosis : clinicopathological and molecular features of a rare malignant bone marrow disease
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Maße
-
20 cm
- Umfang
-
VII, 97 Bl.
- Sprache
-
Englisch
- Anmerkungen
-
Ill., graph. Darst.
Freiburg (Breisgau), Univ., Diss., 2013
- Klassifikation
-
Medizin, Gesundheit
- Urheber
-
Kapp-Schwoerer, Silke
- Inhaltsverzeichnis
- Rechteinformation
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Letzte Aktualisierung
-
11.06.2025, 14:05 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Hochschulschrift
Beteiligte
- Kapp-Schwoerer, Silke
Ähnliche Objekte (12)
Myelofibrosis
Vitamin-D Deficiency and Myelofibrosis: A Rare but Reversible Association
Bone Marrow Plasminogen Activator in Malignant Disease
Multi-omics differences in the bone marrow between essential thrombocythemia and prefibrotic primary myelofibrosis
Autocrine Tnf signaling favors malignant cells in myelofibrosis in a Tnfr2-dependent fashion
Myelofibrosis Treatment Algorithm 2018
Novel approaches in myelofibrosis
Splenic Marginal Zone Lymphoma with Prominent Myelofibrosis Mimicking Triple-Negative Primary Myelofibrosis
Long-term effects of ruxolitinib versus best available therapy on bone marrow fibrosis in patients with myelofibrosis
Long-term effects of ruxolitinib versus best available therapy on bone marrow fibrosis in patients with myelofibrosis
Prefibrotic myelofibrosis: treatment algorithm 2018
Digital Papillary Adenocarcinoma, a Rare Malignant Tumor
Myelofibrosis
Vitamin-D Deficiency and Myelofibrosis: A Rare but Reversible Association
Bone Marrow Plasminogen Activator in Malignant Disease
Multi-omics differences in the bone marrow between essential thrombocythemia and prefibrotic primary myelofibrosis
Autocrine Tnf signaling favors malignant cells in myelofibrosis in a Tnfr2-dependent fashion
Myelofibrosis Treatment Algorithm 2018
Novel approaches in myelofibrosis
Splenic Marginal Zone Lymphoma with Prominent Myelofibrosis Mimicking Triple-Negative Primary Myelofibrosis
Long-term effects of ruxolitinib versus best available therapy on bone marrow fibrosis in patients with myelofibrosis
Long-term effects of ruxolitinib versus best available therapy on bone marrow fibrosis in patients with myelofibrosis
Prefibrotic myelofibrosis: treatment algorithm 2018
Digital Papillary Adenocarcinoma, a Rare Malignant Tumor
Myelofibrosis
Vitamin-D Deficiency and Myelofibrosis: A Rare but Reversible Association
Bone Marrow Plasminogen Activator in Malignant Disease
Multi-omics differences in the bone marrow between essential thrombocythemia and prefibrotic primary myelofibrosis
Autocrine Tnf signaling favors malignant cells in myelofibrosis in a Tnfr2-dependent fashion
Myelofibrosis Treatment Algorithm 2018
Novel approaches in myelofibrosis
Splenic Marginal Zone Lymphoma with Prominent Myelofibrosis Mimicking Triple-Negative Primary Myelofibrosis
Long-term effects of ruxolitinib versus best available therapy on bone marrow fibrosis in patients with myelofibrosis
Long-term effects of ruxolitinib versus best available therapy on bone marrow fibrosis in patients with myelofibrosis
Prefibrotic myelofibrosis: treatment algorithm 2018